These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34465338)

  • 1. Effects of valsartan combined with α-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis.
    Sun F; Jiang D; Cai J
    BMC Endocr Disord; 2021 Aug; 21(1):178. PubMed ID: 34465338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative Effects of Valsartan Alone or Combined with Alpha-lipoic Acid on Inflammatory Cytokines and Renal Function in Early-stage Diabetic Kidney Disease.
    Jiang Z; Tan Z; Meng F; Li X
    J Coll Physicians Surg Pak; 2019 Oct; 29(10):1009-1011. PubMed ID: 31564281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Valsartan and Amlodipine Tablets Combined with α-Lipoic Acid on T-AOC, IL-6 and β2-MG Levels in Patients with Diabetic Nephropathy.
    Su F; Xia Q
    Altern Ther Health Med; 2023 Jul; 29(5):126-131. PubMed ID: 37023313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xuebijing injection combined with alprostadil in the treatment of diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Hao N; Liu Y; Guo L; Li W; Zhao P
    Medicine (Baltimore); 2024 Jun; 103(24):e32095. PubMed ID: 38875385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Salvianolate Combined With Western Medicine on Diabetic Nephropathy: A Systematic Review and Meta-Analysis.
    Shen Y; Wang S; Liu Y; Ge L; Xia L; Zhang X; Miao Y; Shen J; Zhou Q
    Front Pharmacol; 2020; 11():851. PubMed ID: 32595500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis.
    Wu X; Huang Y; Zhang Y; He C; Zhao Y; Wang L; Gao J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33057690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropathy: a Systematic Review and Meta-Analysis.
    Wang Y; Yang S; Zhou Q; Zhang H; Yi B
    Kidney Blood Press Res; 2019; 44(1):72-87. PubMed ID: 30808855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Alpha-lipoic Acid Supplementation on Human Diabetic Nephropathy: A Systematic Review and Meta-analysis.
    Vakali E; Rigopoulos D; Carrillo AE; Flouris AD; Dinas PC
    Curr Diabetes Rev; 2022; 18(6):e140921196457. PubMed ID: 34521329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis.
    Guan H; Ye M; Fang C; Zhang L; Han P; Qiu S; Fang X; Li L
    Medicine (Baltimore); 2020 Dec; 99(50):e23507. PubMed ID: 33327292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary exosomes as a novel biomarker for evaluation of α-lipoic acid's protective effect in early diabetic nephropathy.
    Sun H; Yao W; Tang Y; Zhuang W; Wu D; Huang S; Sheng H
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28116765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of α lipoic acid combined with olmesartan medoxomil on blood glucose and oxidation indicators in patients with diabetic nephropathy: A protocol for a parallel, randomized, double-blind, controlled clinical trial.
    Jiao S; Dong Y; Chang X; Wu Y; Li H
    Medicine (Baltimore); 2022 Apr; 101(17):e29080. PubMed ID: 35512068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study.
    Morcos M; Borcea V; Isermann B; Gehrke S; Ehret T; Henkels M; Schiekofer S; Hofmann M; Amiral J; Tritschler H; Ziegler R; Wahl P; Nawroth PP
    Diabetes Res Clin Pract; 2001 Jun; 52(3):175-83. PubMed ID: 11323087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials.
    Akbari M; Ostadmohammadi V; Lankarani KB; Tabrizi R; Kolahdooz F; Khatibi SR; Asemi Z
    Metabolism; 2018 Oct; 87():56-69. PubMed ID: 29990473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Bailing capsules in the treatment of type 2 diabetic nephropathy: a meta-analysis.
    Sheng X; Dong Y; Cheng D; Wang N; Guo Y
    Ann Palliat Med; 2020 Nov; 9(6):3885-3898. PubMed ID: 33222468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy.
    Dugbartey GJ; Alornyo KK; N'guessan BB; Atule S; Mensah SD; Adjei S
    Biomed Pharmacother; 2022 May; 149():112818. PubMed ID: 35286963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vitamin D on Urinary Albumin Excretion in Diabetic Nephropathy Patients: A Meta-analysis of Randomized Controlled Trials.
    He L; Zhou L; Zhao TY; Witherspoon AT; Ouyang L
    Iran J Kidney Dis; 2022 Sep; 16(5):273-279. PubMed ID: 36178860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant for treatment of diabetic nephropathy: A systematic review and meta-analysis.
    Kandhare AD; Mukherjee A; Bodhankar SL
    Chem Biol Interact; 2017 Dec; 278():212-221. PubMed ID: 29108777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy: a meta-analysis.
    Wang B; Chen S; Yan X; Li M; Li D; Lv P; Ti G
    Altern Ther Health Med; 2015; 21(1):36-44. PubMed ID: 25599431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of Niaoduqing granules in the treatment of diabetic kidney disease: a systematic review and meta-analysis.
    Song C; Zhu Z; Liu L; Liu S; Li Y; Xiao Y; Wu C; Nan Z
    Front Pharmacol; 2023; 14():1180751. PubMed ID: 37475716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.